One in three American adults now lives with metabolic dysfunction-associated steatotic liver disease. The condition once known as nonalcoholic fatty liver disease has moved from specialist clinics into mainstream conversation. TikTok videos tagged #liverhealth and #fattyliver have racked up more than 161 million views in recent months. Sales of liver support supplements have surged. Consumers scan their bloodwork results and reach for bottles promising detoxification and metabolic reset.
Yet hepatologists keep delivering the same message. Lifestyle changes outperform pills. The liver performs over 500 functions. It processes nutrients, stores vitamins, clears toxins, regulates blood clotting. When fat accumulates inside its cells, inflammation follows. Fatigue appears. Abdominal discomfort sets in. Left unchecked, the disease can progress to scarring, cirrhosis, even cancer.
Business Insider reported this spring that searches for “liver health” on the Vitamin Shoppe website jumped 700 percent in the first half of 2026. Sales of popular products from brands Dose and ReviveMD rose 160 percent and 80 percent respectively. CVS saw a 40 percent increase in sales of 11 liver-specific items the previous year. Sharon Leite, chief executive of Vitamin Shoppe, told the publication that customers want to take control of their health through prevention rather than quick fixes.
A survey of 2,000 U.S. adults commissioned by the retailer found 53 percent consider liver health very important to overall wellness. Top ingredients in demand include vitamin D, milk thistle, turmeric, ginger, dandelion, choline and N-acetylcysteine. Thorne has noted particular interest among women focused on hormone balance. Influencers on social media push blends that claim to support the organ’s natural processes. Many of those videos double as sales pitches.
But the evidence for most of these products remains thin. Dr. Robert J. Fontana, a hepatologist at University of Michigan Health, points to the rise in obesity and diabetes as the real driver behind increased awareness of MASLD, which affects about 35 percent of U.S. adults. COVID-era increases in alcohol consumption added fuel. New medications, including GLP-1 drugs approved for related conditions in 2025, have also drawn attention to liver health.
Dr. Binu John at the University of Miami offers straightforward advice. Maintain a healthy weight. Follow a Mediterranean diet rich in vegetables, whole grains, healthy fats and lean protein. Limit alcohol. Exercise regularly. Avoid unnecessary medications and supplements. For those with diabetes, obesity or metabolic syndrome, routine bloodwork followed by non-invasive tests when needed gives clearer answers than any capsule. Managing the underlying risk factors matters more than any single nutrient.
The Mayo Clinic reviewed the supplement landscape in January 2026. Lifestyle changes such as reaching a healthy weight, eating well and staying active remain the most effective approach to managing MASLD. Vitamins and supplements cannot cure the condition and should never replace those habits. Still, researchers continue to examine certain compounds used alongside lifestyle measures.
Mayo Clinic researchers noted that vitamin E may boost the liver’s natural antioxidants, reduce inflammation and scarring, and help prevent additional fat buildup. Omega-3 fatty acids show potential to lower liver fat and possibly slow scarring, though results vary across studies. Beta carotene, lycopene from tomatoes and curcumin from turmeric appear in lab and small human studies to offer antioxidant protection and reduce inflammation. More research is required before firm recommendations can be made. Liver cleanse and detox products generally receive a warning. Some can actually harm the organ.
Milk thistle appears frequently on store shelves. A large review cited by GoodRx found it improved liver enzymes in people with fatty liver disease. Yet experts caution that enzyme improvement does not always translate to meaningful clinical benefit. Probiotics, glutathione precursors like NAC, and CoQ10 attract interest but lack definitive proof in large trials.
The commercial opportunity has not gone unnoticed. The global market for liver health supplements stood at $1.64 billion in 2025. Fortune Business Insights projects growth to $2.56 billion by 2034 at a compound annual rate of 4.75 percent. North America held nearly 39 percent of the market last year. Rising disease rates, an aging population, and consumer preference for herbal and preventive products drive the expansion. In June 2025, Guttify introduced its Liver Lift Kit containing milk thistle, dandelion and moringa. Earlier studies, including one from Duke-NUS Medical School in 2022, suggested vitamin B12 and folic acid might help prevent or reverse advanced fatty liver in certain cases.
While supplements generate headlines and revenue, pharmaceutical progress has accelerated. In May 2026, ScienceDaily covered results from a University of California San Diego trial of an experimental drug called ION224. Developed with Ionis Pharmaceuticals, the compound blocks an enzyme known as DGAT2 that the liver uses to produce and store fat.
Dr. Rohit Loomba, chief of gastroenterology and hepatology at UC San Diego and principal investigator, described the findings as a pivotal advance. The Phase IIb trial enrolled 160 adults with MASH, the more severe form involving inflammation and fibrosis. Participants received monthly injections for 51 weeks. About 60 percent on the highest dose showed meaningful improvements in liver health compared with placebo. The drug was generally well tolerated. “By blocking DGAT2, we’re interrupting the disease process at its root cause, stopping fat accumulation and inflammation right in the liver,” Loomba said. He added that if confirmed in larger trials, the approach could offer a targeted therapy that halts damage before it reaches life-threatening stages.
Existing approved treatments already mark progress. Madrigal Pharmaceuticals’ Rezdiffra, the first drug specifically approved for MASH with fibrosis, gained attention in 2025. Semaglutide, sold as Wegovy and Ozempic, received expanded approval to treat MASH with moderate to advanced scarring when combined with diet and exercise. These GLP-1 medications reduce liver fat partly through weight loss but also appear to offer direct protective effects on the organ.
University Hospitals in Cleveland highlighted in 2025 that semaglutide may halt and even reverse severe liver disease in some patients. Dr. Seth Sclair, a hepatologist there, called the current period exciting for steatotic liver disease treatment. Several drugs can now slow or stop progression in certain individuals.
Consumer Lab updated its review of fatty liver supplements as recently as June 2026. It continues to examine claims around broccoli sprout extract and herbal blends such as Dose For Your Liver. The organization stresses that solid evidence remains limited for many products despite aggressive marketing.
Public health experts worry the wellness frenzy distracts from root causes. Poor diet, sedentary behavior, excess alcohol and uncontrolled diabetes and obesity drive most cases. Blood tests that once seemed routine now trigger panic when ALT or AST levels appear elevated. Social media amplifies fear and promises easy solutions. But the liver is resilient. Modest weight loss of 7 to 10 percent can significantly reduce fat accumulation. Consistent movement, fiber-rich eating patterns and alcohol moderation produce measurable changes on imaging and biopsy.
Physicians repeatedly tell patients the same thing. Get screened if you have risk factors. Discuss all supplements with your doctor. Many products are safe in moderation. Few have been proven to alter disease course. The newest drugs offer hope for those with advanced disease. For the majority still in early stages, daily habits deliver the strongest protection.
So the liver health obsession reflects both genuine medical need and clever marketing. Sales will likely keep climbing. Influencers will keep posting. Scientists will keep testing whether specific nutrients or novel molecules can tip the balance. But the fundamentals have not shifted. A balanced diet, regular exercise and avoidance of excess remain the foundation. Everything else is supplementary at best.
WebProNews is an iEntry Publication